Cardiomyocyte-specific conditional knockout of the histone chaperone HIRA in mice results in hypertrophy, sarcolemmal damage and focal replacement fibrosis

ABSTRACT HIRA is the histone chaperone responsible for replication-independent incorporation of histone variant H3.3 within gene bodies and regulatory regions of actively transcribed genes, and within the bivalent promoter regions of developmentally regulated genes. The HIRA gene lies within the 22q11.2 deletion syndrome critical region; individuals with this syndrome have multiple congenital heart defects. Because terminally differentiated cardiomyocytes have exited the cell cycle, histone variants should be utilized for the bulk of chromatin remodeling. Thus, HIRA is likely to play an important role in epigenetically defining the cardiac gene expression program. In this study, we determined the consequence of HIRA deficiency in cardiomyocytes in vivo by studying the phenotype of cardiomyocyte-specific Hira conditional-knockout mice. Loss of HIRA did not perturb heart development, but instead resulted in cardiomyocyte hypertrophy and susceptibility to sarcolemmal damage. Cardiomyocyte degeneration gave way to focal replacement fibrosis and impaired cardiac function. Gene expression was widely altered in Hira conditional-knockout hearts. Significantly affected pathways included responses to cellular stress, DNA repair and transcription. Consistent with heart failure, fetal cardiac genes were re-expressed in the Hira conditional knockout. Our results suggest that transcriptional regulation by HIRA is crucial for cardiomyocyte homeostasis. Summary: Deletion of HIRA, a gene encoding a histone chaperone that lies within the critical region of 22q11.2 deletion syndrome, alters cardiac gene expression and leads to cardiomyopathy.

[1]  S. Eliez,et al.  22q11.2 deletion syndrome , 2019, Nature Reviews Disease Primers.

[2]  A. Mencalha,et al.  Post-translational modifications disclose a dual role for redox stress in cardiovascular pathophysiology. , 2015, Life sciences.

[3]  P. Scambler,et al.  Histone Chaperone HIRA in Regulation of Transcription Factor RUNX1* , 2015, The Journal of Biological Chemistry.

[4]  D. Townsend,et al.  Early right ventricular fibrosis and reduction in biventricular cardiac reserve in the dystrophin-deficient mdx heart. , 2015, American journal of physiology. Heart and circulatory physiology.

[5]  J. Workman,et al.  Histone exchange, chromatin structure and the regulation of transcription , 2015, Nature Reviews Molecular Cell Biology.

[6]  John J. Cole,et al.  HIRA orchestrates a dynamic chromatin landscape in senescence and is required for suppression of neoplasia , 2014, Genes & development.

[7]  S. Senyo,et al.  Cardiac regeneration based on mechanisms of cardiomyocyte proliferation and differentiation. , 2014, Stem cell research.

[8]  G. Almouzni,et al.  Histone chaperones: assisting histone traffic and nucleosome dynamics. , 2014, Annual review of biochemistry.

[9]  Stephan Eliez,et al.  Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome. , 2014, The American journal of psychiatry.

[10]  A. Domenighetti,et al.  Vinculin directly binds zonula occludens-1 and is essential for stabilizing connexin-43-containing gap junctions in cardiac myocytes , 2014, Journal of Cell Science.

[11]  L. D. de Windt,et al.  Regulation of fetal gene expression in heart failure. , 2013, Biochimica et biophysica acta.

[12]  S. Rafii,et al.  Hira-Dependent Histone H3.3 Deposition Facilitates PRC2 Recruitment at Developmental Loci in ES Cells , 2013, Cell.

[13]  G. Almouzni,et al.  Transcription Recovery after DNA Damage Requires Chromatin Priming by the H3.3 Histone Chaperone HIRA , 2013, Cell.

[14]  D. Kobayashi,et al.  Tetralogy of Fallot with complete DiGeorge syndrome: report of a case and a review of the literature. , 2013, Congenital heart disease.

[15]  E. Marbán,et al.  Cardiomyocyte proliferation and progenitor cell recruitment underlie therapeutic regeneration after myocardial infarction in the adult mouse heart , 2013, EMBO molecular medicine.

[16]  Zhiguo Zhang,et al.  Histone chaperones in nucleosome assembly and human disease , 2013, Nature Structural &Molecular Biology.

[17]  A. Hamiche,et al.  Chaperoning the histone H3 family. , 2012, Biochimica et biophysica acta.

[18]  P. Adams,et al.  Lessons from senescence: Chromatin maintenance in non-proliferating cells. , 2012, Biochimica et Biophysica Acta.

[19]  A. Latos-Bieleńska,et al.  Frequency of 22q11.2 microdeletion in children with congenital heart defects in western poland , 2010, BMC pediatrics.

[20]  B. Fleischmann,et al.  Cardiomyocyte cell cycle control and growth estimation in vivo--an analysis based on cardiomyocyte nuclei. , 2010, Cardiovascular research.

[21]  K. Momma Cardiovascular anomalies associated with chromosome 22q11.2 deletion syndrome. , 2010, The American journal of cardiology.

[22]  S. Rafii,et al.  Distinct Factors Control Histone Variant H3.3 Localization at Specific Genomic Regions , 2010, Cell.

[23]  Pál Pacher,et al.  Measurement of cardiac function using pressure–volume conductance catheter technique in mice and rats , 2008, Nature Protocols.

[24]  Joel C. Miller,et al.  Cardiac-Myocyte-Specific Excision of the Vinculin Gene Disrupts Cellular Junctions, Causing Sudden Death or Dilated Cardiomyopathy , 2007, Molecular and Cellular Biology.

[25]  Rugang Zhang,et al.  Molecular Dissection of Formation of Senescence-Associated Heterochromatin Foci , 2007, Molecular and Cellular Biology.

[26]  W. Edwards,et al.  Identification of a metavinculin missense mutation, R975W, associated with both hypertrophic and dilated cardiomyopathy. , 2006, Molecular genetics and metabolism.

[27]  M. Weyand,et al.  Systematic assessment of atypical deletions reveals genotype–phenotype correlation in 22q11.2 , 2005, Journal of Medical Genetics.

[28]  Brian E. Schwartz,et al.  Transcriptional activation triggers deposition and removal of the histone variant H3.3. , 2005, Genes & development.

[29]  G. Almouzni,et al.  Histone H3.1 and H3.3 Complexes Mediate Nucleosome Assembly Pathways Dependent or Independent of DNA Synthesis , 2004, Cell.

[30]  S. Henikoff,et al.  Histone H3 variants specify modes of chromatin assembly , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[31]  S. Henikoff,et al.  The histone variant H3.3 marks active chromatin by replication-independent nucleosome assembly. , 2002, Molecular cell.

[32]  M. Keating,et al.  Metavinculin Mutations Alter Actin Interaction in Dilated Cardiomyopathy , 2002, Circulation.

[33]  Peter D. Adams,et al.  HIRA, the Human Homologue of Yeast Hir1p and Hir2p, Is a Novel Cyclin-cdk2 Substrate Whose Expression Blocks S-Phase Progression , 2001, Molecular and Cellular Biology.

[34]  G. Taffet,et al.  The absence of desmin leads to cardiomyocyte hypertrophy and cardiac dilation with compromised systolic function. , 1999, Journal of molecular and cellular cardiology.

[35]  R. Weksberg,et al.  Phenotype of adults with the 22q11 deletion syndrome: A review. , 1999, American journal of medical genetics.

[36]  P. Scambler,et al.  HIRA, a DiGeorge syndrome candidate gene, is required for cardiac outflow tract septation. , 1999, Circulation research.

[37]  K. Devriendt,et al.  The annual incidence of DiGeorge/velocardiofacial syndrome. , 1998, Journal of medical genetics.

[38]  A. Green,et al.  Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. , 1997, Journal of medical genetics.

[39]  R. Kucherlapati,et al.  Molecular definition of 22q11 deletions in 151 velo-cardio-facial syndrome patients. , 1997, American journal of human genetics.

[40]  L. Thornell,et al.  Null mutation in the desmin gene gives rise to a cardiomyopathy. , 1997, Journal of molecular and cellular cardiology.

[41]  M. Franklin,et al.  Cardiomyocyte DNA synthesis and binucleation during murine development. , 1996, The American journal of physiology.

[42]  B. Lowes,et al.  Dilated cardiomyopathy associated with deficiency of the cytoskeletal protein metavinculin. , 1996, Circulation.

[43]  I. Dunham,et al.  Isolation of a putative transcriptional regulator from the region of 22q11 deleted in DiGeorge syndrome, Shprintzen syndrome and familial congenital heart disease. , 1993, Human molecular genetics.

[44]  M. Digilio,et al.  Cardiac defects and results of cardiac surgery in 22q11.2 deletion syndrome. , 2008, Developmental disabilities research reviews.

[45]  Adrian A Canutescu,et al.  Formation of MacroH2A-containing senescence-associated heterochromatin foci and senescence driven by ASF1a and HIRA. , 2005, Developmental cell.

[46]  I. V. Uryvaeva,et al.  Mitotic polyploidization of mouse heart myocytes during the first postnatal week , 2004, Cell and Tissue Research.

[47]  N. Dalton,et al.  Animal Model Heterozygous Inactivation of the Vinculin Gene Predisposes to Stress-Induced Cardiomyopathy , 2004 .

[48]  A. Katz,et al.  Evidence that human cardiac myocytes divide after myocardial infarction. , 2001, The New England journal of medicine.